Cookies on this site

Chunxiao Song has been announced as one of nine finalists for the 2025 UK Blavatnik Awards for Young Scientists, in the Chemical Sciences division.

Chunxiao Song

The Blavatnik Family Foundation and The New York Academy of Sciences have announced the finalists for the eighth Blavatnik Awards for Young Scientists in the UK. The Awards recognise scientific advances by UK researchers across three divisions – Life Sciences, Chemical Sciences, and Physical Sciences & Engineering.

Associate Professor Chunxiao Song of Ludwig Oxford has been selected from a pool of 94 nominees as a finalist in the Chemical Sciences division for his development of a state-of-the-art sequencing methods to detect DNA and RNA modifications, enabling early cancer detection and leading to the founding of a $410 million biotech company.

Chunxiao said: ‘I was thrilled to learn of my selection as a Finalist for the 2025 UK Blavatnik Awards. My research team and I have worked tirelessly to produce technologies capable of detecting DNA and RNA modifications to enable early cancer detection and we are delighted that this work is being recognised for its ability to help patients and cancer therapy.’

He is joined by fellow Chemical Sciences finalists Liam Ball at the University of Nottingham, an organic chemist developing efficient methods for safe and sustainable synthesis of molecules vital to healthcare and agriculture, and Brianna Heazlewood at the University of Liverpool, a physical chemist who has developed instruments that characterise complex chemical reactions at extremely cold temperatures, providing new insights into the chemistry of space and other challenging environments.

On Wednesday 4th March, the three 2025 Laureates will be announced from the nine finalists at a gala dinner and awards ceremony. The three Laureates will each receive an unrestricted award of £100,000. The remaining six Finalists will each receive £30,000.

Professor Nicholas B. Dirks, President and CEO of The New York Academy of Sciences and Chair of the Awards’ Scientific Advisory Council, said: ‘I wish these nine Finalists a hearty congratulations and best of luck. They demonstrate great promise and potential through their bold, scientific research. Their work lays the foundation for treatments and discoveries that can help people, our planet, and the pursuit of science itself.’

Similar stories

Salum Mshamu named a 2026 TIME Trailblazer

Congratulations to Salum Mshamu on being selected as one of TIME’s inaugural 2026 Trailblazers: Designing and Making the Future. A University of Oxford DPhil student, Salum was recognised for his contribution to research showing how improved housing design can reduce malaria and other childhood illnesses.

University of Oxford announces next-generation Ai initiative to detect, assess and respond to pandemics

The University of Oxford has been awarded €8 million through the European Union’s Horizon Europe programme to coordinate the development of the Pandemics AI Observatory (PANDAI).

Inaugural Sir John Bell Lecture Celebrates a Legacy of Innovation and the Future of Human Health

Creating a map of every cell in the human body is one of the most ambitious goals in modern science. Through the Human Cell Atlas, an international collaboration involving thousands of researchers worldwide, scientists are building a reference map of human cells that is reshaping understanding of health and disease.

Team ATLAS sets out strategy to investigate cancer avoidance as part of Cancer Grand Challenges

A new position paper from team ATLAS sets out plans to build a cancer antibody atlas to investigate why some people avoid cancer, while others develop disease.

MORU’s contribution to ASEAN health highlighted during The Princess Royal’s Thailand visit

The visit highlighted MORU’s longstanding contribution to health across Thailand and the wider ASEAN region, and the value of collaboration between Mahidol University and Oxford's Nuffield Department of Medicine.

UK and France launch landmark biomedical and AI health alliance to accelerate research into major diseases

A new partnership will unite expertise, infrastructure and data across borders to accelerate diagnosis, treatment and ultimately prevention of major diseases – starting with women’s health, infectious diseases and pandemic preparedness.